Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Borgel

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Blood|January 1, 1995
Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active geneS Gandrille, D Borgel, V Eschwege-Gufflet, et al.
Blood|November 1, 1995
The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiencyJ Duchemin, S Gandrille, D Borgel, et al.
Human Genetics|January 29, 2010
Novel human pathological mutations. Gene symbol: PROS1. Disease: Protein S deficiencyMaria Pintao, A A Garcia, D Borgel, et al.
Cancer Research|June 5, 2003
"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapiesSusanna M Rybak, Elena Sanovich, Melinda G Hollingshead, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Human Genetics|May 26, 2009
Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiencyMaria C Pintao, A A Garcia, D Borgel, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2011
ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcomaSusan Kenney, David T Vistica, Luke H Stockwin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain functionM Baroni, G Mazzola, T Kaabache, et al.
Cancer Research|October 7, 2004
Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenograftsAnnamaria Rapisarda, Jessica Zalek, Melinda Hollingshead, et al.
Journal of Pediatric Hematology/Oncology|July 29, 2009
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapyDavid T Vistica, Melinda Hollingshead, Suzanne D Borgel, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Blood|January 1, 1995
Identification of 15 different candidate causal point mutations and three polymorphisms in 19 patients with protein S deficiency using a scanning method for the analysis of the protein S active geneS Gandrille, D Borgel, V Eschwege-Gufflet, et al.
Blood|November 1, 1995
The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiencyJ Duchemin, S Gandrille, D Borgel, et al.
Human Genetics|January 29, 2010
Novel human pathological mutations. Gene symbol: PROS1. Disease: Protein S deficiencyMaria Pintao, A A Garcia, D Borgel, et al.
Cancer Research|June 5, 2003
"Vasocrine" formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapiesSusanna M Rybak, Elena Sanovich, Melinda G Hollingshead, et al.
The Biochemical Journal|November 22, 2001
Implication of protein S thrombin-sensitive region with membrane binding via conformational changes in the gamma-carboxyglutamic acid-rich domainD Borgel, P Gaussem, C Garbay, et al.
Human Genetics|May 26, 2009
Gross deletions/duplications in PROS1 are relatively common in point mutation-negative hereditary protein S deficiencyMaria C Pintao, A A Garcia, D Borgel, et al.
Journal of Pediatric Hematology/Oncology|May 10, 2011
ASPS-1, a novel cell line manifesting key features of alveolar soft part sarcomaSusan Kenney, David T Vistica, Luke H Stockwin, et al.
Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain functionM Baroni, G Mazzola, T Kaabache, et al.
Cancer Research|October 7, 2004
Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenograftsAnnamaria Rapisarda, Jessica Zalek, Melinda Hollingshead, et al.
Journal of Pediatric Hematology/Oncology|July 29, 2009
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapyDavid T Vistica, Melinda Hollingshead, Suzanne D Borgel, et al.
Pageof 4